Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes

OBJECTIVE—Activation of the receptor for advanced glycation end products (RAGE) in diabetic vasculature is considered to be a key mediator of atherogenesis. This study examines the effects of deletion of RAGE on the development of atherosclerosis in the diabetic apoE(−/−) model of accelerated athero...

Descripción completa

Detalles Bibliográficos
Autores principales: Soro-Paavonen, Aino, Watson, Anna M.D., Li, Jiaze, Paavonen, Karri, Koitka, Audrey, Calkin, Anna C., Barit, David, Coughlan, Melinda T., Drew, Brian G., Lancaster, Graeme I., Thomas, Merlin, Forbes, Josephine M., Nawroth, Peter P., Bierhaus, Angelika, Cooper, Mark E., Jandeleit-Dahm, Karin A.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2008
Materias:
Complications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2518498/
https://www.ncbi.nlm.nih.gov/pubmed/18511846
http://dx.doi.org/10.2337/db07-1808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2518498/
https://www.ncbi.nlm.nih.gov/pubmed/18511846
http://dx.doi.org/10.2337/db07-1808

Ejemplares similares